China Digital Press: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on China Digital Press.

Press releases published on April 23, 2026

Nobel University Launches New Affordable Online Programs for Today’s Career-Focused Students
打破金融 AI 浅层局限:Revolution-AI 官网公布最新技术顾问体系,剑指系统级底层模型
Gate Driver IC Market Trends, Investment Opportunities, and Growth Analysis Through 2033 Featuring Infineon Technologies
Electric Grippers Market Set to Boom Rapidly, Witnessing Strong Growth Through 2033 | ABB Robotics, Festo
Leukemia Inhibitory Factor Market to Surpass $2.65 Billion by 2033 at 9.2% CAGR: Coherent Market Insights
Data Center Cooling Market Trends, Investment Opportunities, and Growth Analysis Through 2033 Featuring Air Enterprises
iTonic Holdings Ltd Granted An Extension of Additional 180-Day by Nasdaq to Regain Compliance with Minimum Bid Price Rule
Vimi Fasteners Takes Center Stage at Fastener Taiwan 2026: A Strategic Leap into the APAC Market
Bodor Laser ocupa el primer lugar mundial en volumen de ventas durante siete años consecutivos, demostrando la fortaleza de su marca mediante un liderazgo sostenido
בודור לייזר דורגה במקום הראשון בנפח המכירות הגלובלי במשך שבע שנים רצופות, והדגימה את חוזק המותג באמצעות מנהיגות מתמשכת.
Bodor Laser Menduduki Peringkat No. 1 dalam Volume Penjualan Global Selama Tujuh Tahun Berturut-turut, Menunjukkan Kekuatan Merek Melalui Kepemimpinan yang Konsisten
Bodor Laser Menduduki Kedudukan No. 1 Jualan Global Selama Tujuh Tahun Berturut-turut, Menyerlahkan Kekuatan Jenama Melalui Kepimpinan Berterusan
Bodor Laser 连续七年全球销量第一,以持久领先彰显品牌实力
Bodor Laser 七年蟬聯全球銷量第一,長期市場領導地位展現品牌實力
iCAUR V27 obtiene la certificación todoterreno L3 de CATARC, consolidando su capacidad de nueva energía con tecnología avanzada
36Kr Holdings Inc. Files 2025 Annual Report on Form 20-F
InnoCare Releases 2026 Q1 Results: Strong Revenue Growth and Sustained Profitability
WeRide Inc. Files Its 2025 Annual Report on Form 20-F
CMS (867.HK; 8A8.SG): NDA for the Seasonal Allergic Rhinitis Indication of Class 1 Innovative Drug MG-K10 Accepted in China
BIOINNOVASIA 2026: 아시아 탈탄소화를 위한 바이오연료, 바이오매스, 바이오카본 및 원료 전략 고도화

Share this page:

Sign up for:

China Digital Press

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.